Stone X Group Inc. Bolt Biotherapeutics, Inc. Transaction History
Stone X Group Inc.
- $1.58 Billion
- Q1 2025
A detailed history of Stone X Group Inc. transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 15,532 shares of BOLT stock, worth $4,970. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,532Holding current value
$4,970% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BOLT
# of Institutions
29Shares Held
18.1MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA3.81MShares$1.22 Million0.1% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.52MShares$1.13 Million0.38% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$881,4190.08% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$605,2691.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$374,3050.0% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $12M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...